AIM: The main purposes of this study were to evaluate the efficacy of electrochemotherapy in head and neck tumours, to assess the local tumour control, the safety profile and its impact on the patients' quality of life. METHODS: This is a multicenter prospective, non-randomized phase II trial. This trial was carried out at the Dermatologic Clinic of University of Rome "La Sapienza", at the Dermatologic Clinic of University of Chieti and at the Dermatologic Clinic of University of Turin. 55 patients with head and neck cancers were recruited. The electrochemotherapy procedure was carried out according to the ESOPE guidelines. Statistical analyses were performed using Stata/SE12.0 Statistical Software RESULTS: A significant clinical response was achieved in 50/55 patients with 91% of objective response rate (OR). 33 of 55 patients showed a CR (60%); 17 treated patients had a PR (31%). A significantly higher CR rate was obtained in patients not previously treated by surgery (15/19; 79%), with respect to those with a previous excision of the tumour (14/30; 47%) (p=0.025). An additional parameter influencing response is represented by anesthesia: patients treated by ECT with general anesthesia were characterized by significantly higher CR rate (68%) than those treated with local anesthesia (27%) (p=0.014). CONCLUSIONS: Our experience confirmed high efficiency in local tumour control, excellent toxicity profile, tissue preservation with good cosmetic and functional results, even with repeated applications. ECT can represent a first-line treatment in the local management of head and neck cancers.

AIM: The main purposes of this study were to evaluate the efficacy of electrochemotherapy in head and neck tumours, to assess the local tumour control, the safety profile and its impact on the patients' quality of life. METHODS: This is a multicenter prospective, non-randomized phase II trial. This trial was carried out at the Dermatologic Clinic of University of Rome "La Sapienza", at the Dermatologic Clinic of University of Chieti and at the Dermatologic Clinic of University of Turin. 55 patients with head and neck cancers were recruited. The electrochemotherapy procedure was carried out according to the ESOPE guidelines. Statistical analyses were performed using Stata/SE12.0 Statistical Software RESULTS: A significant clinical response was achieved in 50/55 patients with 91% of objective response rate (OR). 33 of 55 patients showed a CR (60%); 17 treated patients had a PR (31%). A significantly higher CR rate was obtained in patients not previously treated by surgery (15/19; 79%), with respect to those with a previous excision of the tumour (14/30; 47%) (p=0.025). An additional parameter influencing response is represented by anesthesia: patients treated by ECT with general anesthesia were characterized by significantly higher CR rate (68%) than those treated with local anesthesia (27%) (p=0.014). CONCLUSIONS: Our experience confirmed high efficiency in local tumour control, excellent toxicity profile, tissue preservation with good cosmetic and functional results, even with repeated applications. ECT can represent a first-line treatment in the local management of head and neck cancers.

Electrochemotherapy in non-melanoma head and neck skin cancers: a three centers experience and literature review / Rotunno, Roberta; Marenco, Federica; Ribero, Simone; Calvieri, Stefano; Amerio, Paolo; Curatolo, Pietro; Quaglino, Pietro. - In: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. - ISSN 0392-0488. - ELETTRONICO. - 151:6(2016), pp. 610-618.

Electrochemotherapy in non-melanoma head and neck skin cancers: a three centers experience and literature review.

Rotunno, Roberta;Calvieri, Stefano;Curatolo, Pietro;
2016

Abstract

AIM: The main purposes of this study were to evaluate the efficacy of electrochemotherapy in head and neck tumours, to assess the local tumour control, the safety profile and its impact on the patients' quality of life. METHODS: This is a multicenter prospective, non-randomized phase II trial. This trial was carried out at the Dermatologic Clinic of University of Rome "La Sapienza", at the Dermatologic Clinic of University of Chieti and at the Dermatologic Clinic of University of Turin. 55 patients with head and neck cancers were recruited. The electrochemotherapy procedure was carried out according to the ESOPE guidelines. Statistical analyses were performed using Stata/SE12.0 Statistical Software RESULTS: A significant clinical response was achieved in 50/55 patients with 91% of objective response rate (OR). 33 of 55 patients showed a CR (60%); 17 treated patients had a PR (31%). A significantly higher CR rate was obtained in patients not previously treated by surgery (15/19; 79%), with respect to those with a previous excision of the tumour (14/30; 47%) (p=0.025). An additional parameter influencing response is represented by anesthesia: patients treated by ECT with general anesthesia were characterized by significantly higher CR rate (68%) than those treated with local anesthesia (27%) (p=0.014). CONCLUSIONS: Our experience confirmed high efficiency in local tumour control, excellent toxicity profile, tissue preservation with good cosmetic and functional results, even with repeated applications. ECT can represent a first-line treatment in the local management of head and neck cancers.
AIM: The main purposes of this study were to evaluate the efficacy of electrochemotherapy in head and neck tumours, to assess the local tumour control, the safety profile and its impact on the patients' quality of life. METHODS: This is a multicenter prospective, non-randomized phase II trial. This trial was carried out at the Dermatologic Clinic of University of Rome "La Sapienza", at the Dermatologic Clinic of University of Chieti and at the Dermatologic Clinic of University of Turin. 55 patients with head and neck cancers were recruited. The electrochemotherapy procedure was carried out according to the ESOPE guidelines. Statistical analyses were performed using Stata/SE12.0 Statistical Software RESULTS: A significant clinical response was achieved in 50/55 patients with 91% of objective response rate (OR). 33 of 55 patients showed a CR (60%); 17 treated patients had a PR (31%). A significantly higher CR rate was obtained in patients not previously treated by surgery (15/19; 79%), with respect to those with a previous excision of the tumour (14/30; 47%) (p=0.025). An additional parameter influencing response is represented by anesthesia: patients treated by ECT with general anesthesia were characterized by significantly higher CR rate (68%) than those treated with local anesthesia (27%) (p=0.014). CONCLUSIONS: Our experience confirmed high efficiency in local tumour control, excellent toxicity profile, tissue preservation with good cosmetic and functional results, even with repeated applications. ECT can represent a first-line treatment in the local management of head and neck cancers.
Electrochemotherapy, Head and neck skin cancers, Treatment
01 Pubblicazione su rivista::01a Articolo in rivista
Electrochemotherapy in non-melanoma head and neck skin cancers: a three centers experience and literature review / Rotunno, Roberta; Marenco, Federica; Ribero, Simone; Calvieri, Stefano; Amerio, Paolo; Curatolo, Pietro; Quaglino, Pietro. - In: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. - ISSN 0392-0488. - ELETTRONICO. - 151:6(2016), pp. 610-618.
File allegati a questo prodotto
File Dimensione Formato  
Rotunno_Electrochemotherapy_2015.pdf

accesso aperto

Tipologia: Documento in Pre-print (manoscritto inviato all'editore, precedente alla peer review)
Licenza: Creative commons
Dimensione 1.32 MB
Formato Adobe PDF
1.32 MB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/793075
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 16
social impact